LibAirty™ is the first and only airway clearance system to synchronize controlled, app-guided breathing with targeted chest compressions—a clinically proven combination that helps patients clear more sputum than other therapies1. Developed in collaboration with leading pulmonologists and inspired by the proven airway clearance technique of Autogenic Drainage, LibAirty transforms respiratory therapy into a simple, short, daily routine patients can easily perform independently at home, enabling effective lung disease management. The technology received FDA Clearance earlier this year.
“Synchrony Medical is redefining airway clearance,” said Anat Shani, CEO of Synchrony Medical. “Our clinical studies showed that LibAirty enabled patients to clear twice as much sputum as standard vest-based therapy, with improved comfort and increased patient satisfaction. Through the launch of LibAirty in the United States, we look forward to bringing a new standard of care to people living with chronic lung disease across the country.”